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Cryptococcus neoformans and C. gattii are fungal pathogens that are most commonly
found in infections of the central nervous system, which cause life-threatening
meningoencephalitis and can grow as a biofilm. Biofilms are structures conferring
protection and resistance of microorganism to the antifungal drugs. This study
compared the virulence of planktonic and biofilm cells of C. neoformans and C. gattii
in Galleria mellonella model, as well as, the quantification of gene transcripts LAC1,
URE1, and CAP59 by real time PCR. All three of the genes showed significantly
increased expressions in the biofilm conditions for two species of Cryptococcus, when
compared to planktonic cells. C. neoformans and C. gattii cells in the biofilm forms
were more virulent than the planktonic cells in G. mellonella. This suggests that the
biofilm conditions may contribute to the virulence profile. Our results contribute to a
better understanding of the agents of cryptococcosis in the host-yeast aspects of the
interaction.
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INTRODUCTION
Invasive fungal infections (IFIs) are of global importance. An increasing number of cases have
been observed in recent years, and despite current antifungal therapy, mortality rates are high
(Perfect, 2013). Among the pathogens causing IFIs, the yeast Cryptococcus neoformans is the
most prominent in infections of immunocompromised individuals, but C. gattii can also cause
infections in immunocompetent persons (Tortorano et al., 2012; Perfect, 2013; Prates et al.,
2013). The number of cases of cryptococcosis has increased exponentially in the last 30 years
due to the advent of AIDS, the use of immunosuppressive therapy in transplant patients
and the use of chemotherapeutic agents (McClelland et al., 2013). The use of antiretroviral
therapy has been shown to be important in the diagnosis of cryptococcal meningitis in HIV
patients, because increasing of CD4 creates benefits for early diagnosis of cryptococcosis through
serology (Rajasingham and Boulware, 2015). Although the most serious disease manifestation
is meningoencephalitis, cryptococcal pneumony is underdiagnosed and may disseminate to the
central nervous system (CNS) and other sites, depending upon host defenses (Brizendine et al.,
2011).
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Cryptococcus neoformans remains the most prevalent human
pathogen in this genus and is found in the environment
worldwide. Formerly, C. gattii was reported mainly in Australia
and other subtropical and tropical areas, where it was linked to
eucalyptus trees (Smith and Kauffman, 2012). Approximately 1
million cases of cryptococcosis are reported annually, resulting
in 600,000 deaths per year (Stie and Fox, 2012; Zhu et al., 2012)
and approximately one third of cases (Pyrgos et al., 2013) were
related to non-HIV (Bratton et al., 2012; Brizendine et al., 2013).
In Brazil, cryptococcosis has recently been identified as the most
fatal mycosis in AIDS patients (Albuquerque and Rodrigues,
2012).
The mechanisms of pathogenicity and virulence
factors correspond, respectively, to the strategies of the
organism or its products to contribute to its virulence.
The virulence factors of infectious agents are complex
and multifactorial. Polysaccharide synthesis; the capsule;
melanin; ability to growth at 37◦C; extracellular enzymes
such as laccase, phospholipase B, and urease; and biofilm
formation are considered to be virulence factors for
Cryptococcus sp. (Casadevall and Pirofski, 2001; Robertson
and Casadevall, 2009; Zaragoza et al., 2009; Kronstad et al.,
2011).
Biofilms are communities of microorganisms involving
an extracellular matrix attached to a solid surface, whose
development provides important benefits such as increased
nutrient concentrations in the biofilm-liquid interface. The
polymer matrix promotes the adsorption of nutrient molecules
and provides protection from environmental insults (pH
changes, salt concentration, dehydration, aggressive chemicals,
bactericides, antibiotics, predators, lytic bacteria, and heavy
metals). Thus, biofilm microorganisms differ profoundly from
planktonic cells but retain their invasiveness and ability to
evade the host immune system (Costerton et al., 1995;
Sardi et al., 2013). C. neoformans is able to form biofilm
on medical devices, including ventriculoatrial shunt catheters
(Walsh et al., 1986; Bach et al., 1997), peritoneal dialysis
fistula (Braun et al., 1994) and prosthetic cardiac valves
(Banerjee et al., 1997), that highlight the ability of this
organism to adhere to medical devices. Normally, patients
who do not benefit from antifungal therapy and patients who
present serious visual loss or ocular palsies or remain with
high cerebrospinal fluid pressure levels, must be considered
for ventriculoperitoneal placement (Corti et al., 2014). The
increasing use of shunts to manage intracranial hypertension
associated with cryptococcal meningoencephalitis suggests the
importance of investigating the biofilm-forming properties of
this organism (Bach et al., 1997) apud (Martinez and Casadevall,
2015).
Non-conventional animal models of infection can be
used to investigate the virulent traits of a pathogen or
the therapeutic efficacy of a drug, as well as the host–
pathogen interactions. The Galleria mellonella model
represents a versatile experimental system to study
fungal virulence and antifungal efficacy (Mylonakis
et al., 2005; Fuchs and Mylonakis, 2006; Scorzoni et al.,
2013).
The objective of this study was to evaluate the ability of
C. neoformans and C. gattii in biofilm and planktonic forms in
G. mellonella, an alternative model, and to relatively quantify the
gene transcripts involved in virulence by real time PCR.
MATERIALS AND METHODS
Microorganisms
Cryptococcus neoformans var. grubii ATCC 90112, serotype A,
molecular type VNI and C. gattii ATCC 56990, serotype BC,
molecular type VGIII, belonging to the mycology collection
of the Laboratory of Clinical Mycology, Department of
Clinical Analysis, Faculty of Pharmaceutical Sciences, UNESP,
Araraquara were used in this study. Yeasts were kept frozen in
glycerol and subcultured at the time of the experiment.
Biofilm Formation
Both C. neoformans and C. gattii were grown in Sabouraud
dextrose broth (Difco Laboratories, Detroit, MI, USA) with
shaking (200 rpm) at 37◦C until the late log phase (as
determined by a growth curve constructed from absorbance
readings at an optical density of 600 nm). Biofilm formation was
performed according to Martinez and Casadevall (2005), with
some modifications. The cells were collected by centrifugation,
washed twice with phosphate-buffered saline (PBS), counted
with a hemocytometer, and suspended at 1 × 108 cells/mL
in PBS. For each microorganism, 100 µL of the suspension
was added into individual polystyrene wells in 96-well plates
(TPP Trasadingen, Switzerland), and the plates were incubated
at 37◦C without shaking for 2 h for the adhesion stage.
The mature biofilms were formed for 72 h with shaking at
70 rpm at 37◦C in RPMI-1640 (Sigma–Aldrich, St. Louis,
MO, USA) that contained L-glutamine, but not sodium
bicarbonate, was supplemented with 2% glucose, and was
buffered to pH 7.0 using 0.165 M MOPS, (Sigma–Aldrich,
St. Louis, MO, USA). The wells without Cryptococcus cells
were used as controls. Following the adhesion stage, the wells
containing Cryptococcus biofilms were washed three times with
0.05% Tween 20 in PBS to remove non-adhered cryptococci.
Fungal cells that remained attached to the plastic surface
were considered true biofilms. All assays were carried out in
triplicate.
Scanning Electron Microscopy (SEM)
Cryptococcus sp. biofilms were grown on glass coverslips in
microtiter plates with RPMI-1621 for 72 h. Coverslips with
biofilms were then washed three times with PBS and transferred
to another microtiter plate containing 2.5% glutaraldehyde
and incubated for 48 h at 4◦C. The samples were serially
dehydrated in alcohol, fixed in a critical-point drier (Samdri-
790; Tousimis, Rockville, MD, USA), coated with gold-palladium
(Desk-1; Denton Vacuum, Inc., Cherry Hill, NJ, USA), and
viewed with a JEOL (Tokyo, Japan) JSM-6400 scanning electron
microscope at a voltage of 10.0 kV; the image was captured at
10,000×.
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Confocal Laser Scanning Microscopy
(CLSM)
Confocal microscopy was performed according to Martinez and
Casadevall, 2005. Mature biofilms were incubated for 45 min at
37◦C in a solution of CAAF 488 (Concanavalin A conjugated
to Alexa Fluor 488, CAAF; Molecular Probes, USA) and FUN 1
(Molecular Probes, USA). Thus, 4 µL of FUN 1 (10 mM) and
15 µL of CAAF 488 (5 mg/mL) were added to 3 mL of sterile PBS
to obtain 10 µg/mL FUN 1 and 25 µg/mL CAAF. Subsequently,
the coverslips were washed with distilled water taken from the
wells and inverted over 4 µL of Fluoromount-G (Sigma–Aldrich,
USA) that was previously deposited on microscope slides for
observation under confocal microscopy (LSM 510 META, Zeiss).
These trials were conducted in collaboration with the Oswaldo
Cruz Institute in Rio de Janeiro, Department of Cell Biology,
under the coordination of Professor Dr. Marcelo Machado Pelajo.
Metabolic Activity of the Biofilm
The metabolic activity of the biofilms was evaluated according
to (Martinez and Casadevall, 2006b). Semi-quantitative
measurements of planktonic cells, biofilm formations and mature
biofilms of C. neoformans and C. gattii were obtained from the
reduction assay of 2,3-bis (2-methoxy-4-nitro-5-sulfophenyl)-
5-[carbonyl (phenylamino)]-2H-tetrazolium hydroxide (XTT).
The metabolic activity of the cells was measured by mitochondrial
dehydrogenase activity, which reduces the XTT tetrazolium salt
to formazan salt, resulting in a colorimetric change. For this
assay, 50 µL of XTT solution (1 mg/mL in PBS) and 4 µL of a
solution of menadione (1 mM in acetone, Sigma Chemical Co.)
were added to each well. The microplates were incubated at 37◦C
for 5 h and measured at 490 nm (Microplate Reader iMark TM,
BIO-RAD). In all experiments, RPMI was included as a negative
control.
Antifungal Activity of Amphotericin B
The antifungal activity of amphotericin B (AMB) against
planktonic cells and biofilm of C. neoformans and C. gattii
was evaluated by metabolic activity quantification. AMB was
tested in range of concentration equal to 0.0625–128 µg/mL for
48 h of treatment and the fungicidal concentration (FC) was
considered the lower concentration to metabolic activity below
10% (Martinez and Casadevall, 2006b). This assay was performed
XTT assay as previously described.
RNA Isolation and cDNA Synthesis
Total RNA was extracted from Cryptococcus sp. in planktonic and
biofilm formations using TRIZOL R©reagent (Invitrogen, Carlsbad,
CA, EUA, USA) according to the manufacturer’s instructions.
The total RNA from the two situations was treated with DNase
I (Invitrogen, Carlsbad, CA, USA); its concentration and purity
were then determined using a spectrophotometer (GE, Nanovue
Plus). The integrity of the RNA was verified by electrophoresis
with 1% agarose gels. RNA was converted to cDNA using 1 µg
of total RNA and reverse transcriptase (RevertAidTM H Minus
Reverse Transcriptase, Fermentas Life Sciences, Canada).
Real Time PCR of the Genes LAC1,
URE1, and CAP59 in Planktonic and
Biofilm Formations
For the analysis of differential gene expressions by RT-PCR (Real
Time PCR), specific primers were used for genes (Supplementary
Table S1) encoding proteins that are differentially expressed in
C. neoformans (ATCC 90112) and C. gattii (ATCC 56990) strains
in planktonic and biofilm formations. Primers were used at
0.8 µM each for specific forward and reverse primer and cDNA
at 20 ng in 20 µl reactions. The test was performed by Maxima
SYBR Green/ROX qPCR Master Mix (2X) (Thermo Scientific),
and the GAPDH (Glyceraldehyde 3-phosphate dehydrogenase)
gene was used as a reference gene. The reaction program was
50◦C for 2 min, 95◦C for 10 min, and 40 cycles of 95◦C for
15 s, and annealing and synthesis occurred at 60◦C for 1 min.
Following PCR, a melting-curve analysis was performed, which
confirmed that the signal corresponded to a single PCR product
in an Applied Biosystems 7500 cycler. The data were analyzed by
the 2−1CT method (1Ct=1Ct target–1Ct endogen; Livak and
Schmittgen, 2001).
Virulence of Planktonic and Biofilm Cells
in Galleria mellonella
Galleria mellonella caterpillars were produced by EMBRAPA –
Juiz de Fora/MG. Larvae weighing 100–200 mg were selected for
the experiment. The day before the experiment, the larvae were
stored at 37◦C. The biofilms were destroyed with a scraper, and
the cells were counted in a hemocytometer chamber together
with the planktonic cells for the final concentration of 5 × 106
cells/larvae (cell concentrations previously standardized with
planktonic cells). Larvae were infected with 10 µL of inocula
injected into the hemocell through the last proleg using a
Hamilton syringe (Hamilton, EUA). The groups of G. mellonella
were incubated at 37◦C for 7 days, and their death was
monitored daily. The death of the larvae was assessed by the
lack of movement after touching them with tweezers. For each
condition, a total of 16 larvae were used, and each experiment
was repeated at least twice.
Statistical Analysis
All analyses of the dates were performed with GraphPad Prism
5.0 (GraphPad Software, La Jolla, CA, USA). Survival curves were
analyzed by the Log-rank (Mantel-Cox) Test. Real time PCR
was performed statistically by t-test and p-values < 0.05 were
considered significant.
RESULTS
Biofilm Formation
The ability of the C. neoformans and C. gattii strains to
form biofilms in vitro was evaluated. Biofilm formation
by Cryptococcus sp. was demonstrated by SEM. It was
observed that every strain was able to form agglomerates
of cells characterized by a microorganism community firmly
adhered to a non-biological surface and resulting in the
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formation of a mature biofilm. The SEM data provided useful
information on the cell morphology present in the biofilm
structure. The biofilms of C. neoformans (Figures 1A,B) and
C. gattii (Figures 1C,D) strains consist of a dense network of
yeasts.
Confocal Laser Microscopy
Confocal laser scanning microscopy is useful for determining
the viability/activity of the cells adhered to the glass surface and
for analyzing the biofilm thickness. Applying two fluorochromes,
Concanavalin A conjugated to Alexa Fluor 488 (CAAF) and
FUN1, to determine the activity/viability allows the observation
of metabolically active structures in fungal cells. In combination,
the CAAF specifically binds to cell wall polysaccharides.
Images of mature biofilms of C. neoformans ATCC 90112 and
C. gattii ATCC 56990 were acquired by confocal microscopy
(Figures 2A,C). The yellow-orange staining due to FUN1 is dense
in the cytoplasm of metabolically active cell aggregates, while
the green coloration results from the binding of Concanavalin
A to the glucose and mannose moieties of the fungal cell wall.
Orthogonal images of biofilms of the strains were analyzed to
determine their thickness and architecture. Sections of the three-
dimensional images showed that the biofilm of C. neoformans
strain ATCC 90112 has a thickness of 10 µm (Figure 2B),
while C. gattii ATCC 56990 (Figure 2D) has a thickness of
5.4 µm.
Kinetics of Biofilm Formation
The kinetics of biofilm formation on polystyrene microdilution
plates by both Cryptococcus species was compared using the
colorimetric XTT reduction assay to determine metabolic
activity. During a period of 2 h, the Cryptococcus yeast became
firmly adhered to the plastic surface. In the intermediate
stage (12 h) the fungal population increased to form a cell
monolayer, thus initiating the process of biofilm formation.
During the maturation stage (24–72 h), fungal growth involves
the formation of microcolonies consisting of clustered cells
and resulting in compact structures adhering to the plastic
surface.
All samples produced biofilms from 24 to 72 h, and the
initial biofilm formation was observed by 2 h of incubation,
which includes the period of initial adhesion. Over a
period of 12 to 24 h, a continuously increasing biofilm was
observed. The kinetics of biofilm formation was similar in
both strains analyzed and showed no significant differences
(Figure 3).
Antifungal Activity of Amphotericin B
The Supplementary Table S2 shows the values of fungicidal
concentration (FC) of AMB for C. neoformans and C. gattii
in planktonic and biofilm conditions. The FC was 0.5 and
0.25 µg/mL for planktonic cells of C. neoformans and C. gattii,
FIGURE 1 | Scanning electron microscopy (SEM) showing yeast communities adhered to surfaces of glass coverslips indicating the formation of
mature biofilms. (A) Biofilm of Cryptococcus neoformans ATCC 90112 at 750× magnification. (B) Biofilm of C. neoformans ATCC 90112 at 3500× magnification.
(C) Biofilm of C. gattii 56990 at 750× magnification. (D) Biofilm of C. gattii 56990 at 2500× magnification. The blue arrows indicate the self-produced matrix.
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FIGURE 2 | Confocal laser microscopy showing metabolically active cells in mature biofilms. Staining with FUN1 fluorochrome shows the cytoplasm of
metabolically active cells dyed orange–yellow. Staining with concavalin associated with Alexa Fluor 488 (CAAF) shows the presence of mannose in the cell wall of
Cryptococcus sp. Orthogonal images show the thickness and architecture of the biofilms. (A) Mature biofilm of C. neoformans ATCC 90112. (B) Thickness of
mature biofilm of C. neoformans ATCC 90112. (C) Mature biofilm of C. gattii ATCC 56990. (D) Thickness of mature biofilm of C. gattii ATCC 56990.
respectively. In the biofilm condition, we observed an increase of
the fungicidal concentration for C. neoformans as well as C. gattii,
both with concentration of 64.0 µg/mL.
Gene Expressions of LAC1, URE1, and
CAP59 in Biofilms and Planktonic Cells
of Cryptococcus sp.
We used real time PCR assay, with GAPDH as the internal
control. The results of the relative gene expressions of URE1,
LAC1, and CAP59 with biofilm and planktonic cells of
C. neoformans and C. gattii are shown in Figure 4. All three of the
genes showed significantly increased expressions in the biofilm
conditions for two species of Cryptococcus, when compared
to planktonic cells. However, we can see that the increased
expression of genes LAC1 and URE1 was more relevant when
comparing biofilm and planktonic cells of C. gattii. On the
other hand, the increase in CAP59 expression in biofilms of
C. neoformans, when compared with planktonic cells, showed
higher significance than other genes.
Virulence of Planktonic and Biofilm Cells
in Galleria mellonella
To determine an adequate concentration for the virulence tests
with planktonic and biofilm cells, survival curves were created for
different concentrations of yeast (planktonic). The concentration
of 5 × 106 cells/larvae was selected for the experiments (data
not shown). The virulence of the biofilm and planktonic cells
were then compared in vivo in the G. mellonella model. After
4 days, all larvae infected with cells from C. neoformans and
C. gattii biofilms were dead. Larvae infected with planktonic cells
exhibited 30% live larvae when infected with C. neoformans and
80% live larvae when infected with C. gattii in the time of 4 days.
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FIGURE 3 | Kinetics of biofilm formation by Cryptococcus sp. in
microdilution plates as determined by the XTT reduction assay.
It is clear that cells from biofilms are more virulent, and in the
final part of the experiment (7 days), live larvae still remained.
When larvae were infected with planktonic cells, the death rate
did not reach 100% in any of the strains tested (Figure 5).
DISCUSSION
Characterizations of the virulence factors of infectious agents
have revealed great complexity. These factors can be divided into
two categories: those that promote colonization and invasion
as biofilms and those that damage the host by the production
of hydrolytic enzymes (Mendes-Giannini et al., 2000). Biofilm
formation is a common mechanism used by microorganisms to
survive in hostile environments and to colonize and establish
themselves in new environments, thus conferring protection
against their destruction (Hall-Stoodley et al., 2004). Moreover,
fungal biofilms are an increasing clinical problem associated
with high mortality rates (Williams and Costerton, 2012). The
production of melanin (Williamson, 1994), the presence of
capsules (Kwon-Chung et al., 1992), growth at 37◦C (Kraus et al.,
2003), alpha mating type (Kwon-Chung et al., 1982), and the
production of phospholipase (Wright et al., 2004), superoxide
dismutase (Cox et al., 2003), protein kinases (Alspaugh et al.,
1998), and urease (Cox et al., 2000), as well as the synthesis of
polysaccharides (Albuquerque et al., 2014), were phenotypically
and molecularly characterized as in vivo virulence factors related
to invasion and survival in the host (Perfect, 2005).
In this study, strains of C. neoformans and C. gattii were
able to form biofilms. These data were confirmed, and electron
microscopy showed the formation of a dense network of yeasts
with a self-produced extracellular matrix linking the cells of
Cryptococcus sp. Factors such as the characteristics of the
medium and the attachment surface are important for biofilm
development by Cryptococcus sp., and strains of C. neoformans
formed denser biofilms when they were cultured in RPMI 1640
medium (Martinez and Casadevall, 2006a). Biofilm formation is
the most common growth form of microorganisms in nature;
it represents up to 65% of all clinical infections, and given
the high level of antimicrobial resistance, biofilms represent
a huge problem in clinical practice (Donlan and Costerton,
2002; Ramage and Williams, 2013; Martinez and Casadevall,
2015). Biofilm production by Cryptococcus species has often
been described as a strategy associated with chronic infection
resulting from acquired resistance to host immune mechanisms
and antifungal therapy (Martinez et al., 2006).
Amphotericin B activities increased 100X the fungicidal
concentration for both species in biofilm condition. Our
data corroborate to Martinez and Casadevall (2006a), since
the authors showed a lower reduction in metabolic activity
of C. neoformans biofilms when treated with the AMB in
concentrations of 4 and 8 µg/mL, while for planktonic cells, the
metabolic activity is reduced significantly after treatment with
0.5 µg/mL of AMB.
Additionally, our results demonstrated increased expression
of the CAP59 gene in C. neoformans and C. gattii when compared
the biofilm situations to the planktonic mode, suggesting that
this gene may be related to the virulence of this infection.
Although no studies of the CAP59 gene have been described
in biofilms, the importance of this increased expression could
be related to virulence and resistance because the presence
of the capsule prevents the actions of both phagocytes and
antifungal drugs. Few studies have been made of C. gattii;
the genes that regulate virulence were therefore inferred from
the work on C. neoformans. Several virulence factors were
identified using C. neoformans as a model (Perfect, 2005).
Some evidence of differences in the regulation of virulence
genes between the two species have been published (Hicks
and Heitman, 2007; Ngamskulrungroj et al., 2009). Our results
demonstrated increased expression of CAP genes in the biofilms
of C. neoformans and C. gattii. It has been reported that
C. neoformans requires four genes to form the capsule: CAP59,
CAP64, CAP60, and CAP10 (Chang et al., 1996; Grijpstra et al.,
2009). However, unencapsulated homologs of CAP10, CAP59,
and CAP64 have been found in other fungi, suggesting that these
genes may be involved in other processes (García-Rivera et al.,
2004). CAP59 was the first gene that was directly related to the
phenotype of the capsule and to virulence (Chang and Kwon-
Chung, 1994), and it is present in all varieties of C. neoformans
(Alspaugh et al., 1998). Del Poeta (2004) suggested that changes
in the capsule structure could be related to responses to specific
environmental conditions, with important implications for the
host immune response (Del Poeta, 2004).
Our results also demonstrated an increased expression of
laccase, due to expression of LAC1 gene, in the biofilms of
C. neoformans andC. gattii compared to planktonic cells. Laccase,
a phenoloxidase, was described by Zhu et al. (2001) in as an
important virulence factor contributing to the protection of the
fungus against oxidative damage by host phagocytes; it is located
in the cell wall of C. neoformans (Zhu et al., 2001). The enzyme
has also been described for C. gattii (Sorrell, 2001) and may also
modulate the immune response and contribute to the spread of
the disease to the CNS (Qiu et al., 2012).
Urease, codified by the gene URE1, is a metalloenzyme that
catalyzes the hydrolysis of urea to ammonia and carbamate in
physiological conditions and increases the pH. The importance
of this enzyme was described in Helicobacter pylori, Proteus
mirabilis, and its clinical significance was described in
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FIGURE 4 | Expression of the CAP59, laccase (LAC1), and urease (URE1) genes normalized by GAPDH in biofilms and planktonic cells of
C. neoformans and C. gattii. Graphs are plotted in power of 10 to better visualization the results. ∗p < 0.5, ∗∗p < 0.01, and ∗∗∗p < 0.001.
FIGURE 5 | Comparison of virulence from planktonic and biofilm cells of C. neoformans ATCC 90112 and C. gattii ATCC 56990 using Galleria
mellonella as the infection model. The differences were statistically significant (p < 0.05). Graphs represent the average of three repetitions.
C. neoformans, C. gattii, Coccidioides immitis, Histoplasma
capsulatum, Sporothrix schenckii, Trichosporon, and Aspergillus
species (Cox et al., 2000). The urease gene was expressed more
in the biofilm condition in C. neoformans and C. gattii than in
planktonic cells. Urease may promote the transmigration of the
fungus across the blood–brain barrier and facilitate invasion of
the CNS, indicating that urease activity can affect the interaction
of the fungus with the endothelial cells and brain microcapillaries
in the blood–brain barrier (Morrow and Fraser, 2013). Cox et al.
(2000) suggested that urease activity in murine models increases
the survival of mice infected with the mutant urease-negative
gene (Cox et al., 2000), and Feder et al. (2015) demonstrated the
importance of this enzyme in the virulence of C. gattii. In this
work we emphasize, for the first time, the importance of these
three genes in the biofilm condition (Feder et al., 2015).
Additionally, the importance of using alternative animal
models in the study of virulence is increasing due to advantages
such as the absence of ethical issues, cost, and the possibility
of using a large number of individuals (Fuchs and Mylonakis,
2006; Desalermos et al., 2012). The use of G. mellonella in the
study of Cryptococcus virulence is well documented (Firacative
et al., 2014; Desalermos et al., 2015; Trevijano-Contador et al.,
2015). Mylonakis et al. (2002) evaluated the virulence, host
immune responses and efficacy of antifungal compounds and
considered the G. mellonella model suitable for in vivo studies
of C. neoformans (Mylonakis et al., 2002). Fuchs et al. (2010)
also described G. mellonella as an appropriate model for the
study of this yeast (Fuchs et al., 2010) and Desalermos et al.
(2015) studied C. neoformans and various genes involved in the
yeast-host interaction inC. elegans andG.mellonella (Desalermos
et al., 2015). Although insects and mammalians are evolutionary
distance, G. mellonella presents characteristics that support its
use as in vivo model for fungal assays. The presence of at least
six cellular type in hemolymph including phagocytic cells and
the possibility of maintain G. mellonella at 37◦C to simulate the
mammalian temperature are important when considering the use
of this alternative animal model in the study of human fungal
disease (Kavanagh and Reeves, 2004; Fuchs and Mylonakis, 2006;
Desalermos et al., 2012). Moreover, correlations have been found
in mammals with respect to virulence and antifungal treatment
(Mylonakis et al., 2005; London et al., 2006). Biofilm-producer
and non-producer strains of Candida albicans were evaluated in
G. mellonella and showed the biofilm-producer’s high ability to
kill larvae (Cirasola et al., 2013).
As part of the characterization of the biofilms of Cryptococcus
sp., we evaluated the virulence these species in planktonic
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and biofilm conditions in a G. mellonella model. The survival
curve revealed that cells from biofilms are more virulent
than planktonic cells, and this profile was also observed for
C. neoformans and C. gattii. Microorganisms are protected by
the extracellular matrix in biofilms, which is mainly composed
of glycoproteins and polysaccharides. In addition to conferring
protection and resistance, our results showed that biofilm cells
are more virulent and quickly cause death in G. mellonella larvae.
Wand et al. (2012) reported that Acinetobacter baumannii
biofilms could produce higher rates of mortality in the
G. mellonella model compared to planktonic cells of various
clinical isolates. Cirasola et al. (2013) also observed the virulence
of clinical isolates of C. albicans with or without biofilm
capability; the survival of G. mellonella larvae following infection
was reduced and 80% of the infected larvae died within 72 h.
Our studies revealed that Cryptococcus sp. yeast cells that
underwent biofilm formation for the first-time were more
virulent than cells that have not gone through the same
process when analyzed in the G. mellonella model. Other
virulence factors could be involved during biofilm formation
that might help us to understand pathogenic infections in
G. mellonella. A study conducted by Uppuluri and Lopez-Ribot
(2010) showed that cells that detach from a biofilm have a
greater association with mortality than those from planktonic
microorganisms. The dispersed cells of biofilms are more virulent
and cause higher mortality than planktonic cells, which can be
explained by epigenetic alterations within the cells that undergo
biofilm development (Uppuluri and Lopez-Ribot, 2010; Sardi
et al., 2014). Ramage et al. (2012) demonstrated an increased
expression of aspartyl proteinases in C. albicans biofilms
compared with planktonic cells. Their study reported that the
production of proteinase by C. albicans established adhesion,
invasion, and tissue destruction. Their results demonstrate that
the expression of proteinases may be related to the severity of
disease because the expression of these enzymes was significantly
higher in mature biofilms (Ramage et al., 2012). C. neoformans
also produces various proteases and aspartyl proteinases which
have been proposed as potential virulence factors that contribute
to host tissue invasion and colonization by the pathogen. The
increase in proteases could explain the premature death of the
larvae infected with C. neoformans and C. gattii biofilms.
These preliminary results demonstrate the higher virulence
of C. neoformans and C. gattii biofilms. Additional studies are
needed to understand the virulence mechanisms of the biofilms
involved in the premature death of the larvae.
These preliminary results demonstrate the higher resistance
of AMB and virulence in G. mellonella, as well as increased
expression of virulence genes of C. neoformans and C. gattii
biofilms. Additional studies are needed to understand the
virulence mechanisms of the biofilms involved in the premature
death of the larvae.
AUTHOR CONTRIBUTIONS
All authors listed, have made substantial, direct and intellectual
contribution to the work, and approved it for publication.
ACKNOWLEDGMENTS
This work was supported by Rede Nacional de Métodos
Alternativos – Conselho Nacional de Desenvolvimento Científico
e Tecnológico (RENAMA-CNPq) 403586/2012-7; Conselho
Nacional de Desenvolvimento Científico e Tecnológico (CNPq)
and Programa de Apoio ao Desenvolvimento Científico da
Faculdade de Ciências Farmacêuticas da UNESP (PADC/FCF).
SUPPLEMENTARY MATERIAL
The Supplementary Material for this article can be found
online at: http://journal.frontiersin.org/article/10.3389/fmicb.
2016.00290
TABLE S1 | Primers used for RT-pPCR analysis for the virulence analysis.
TABLE S2 | Fungicidal concentration of amphotericin B for planktonic cells
and biofilm madure of Cryptococcus neoformans and Cryptococcus gattii.
REFERENCES
Albuquerque, P. C., Fonseca, F. L., Dutra, F. F., Bozza, M. T., Frases, S.,
Casadevall, A., et al. (2014). Cryptococcus neoformans glucuronoxylomannan
fractions of different molecular masses are functionally distinct. Future
Microbiol. 9, 147–161. doi: 10.2217/fmb.13.163
Albuquerque, P. C., and Rodrigues, M. L. (2012). Research trends on pathogenic
Cryptococcus species in the last 20 years: a global analysis with focus on Brazil.
Future Microbiol. 7, 319–329. doi: 10.2217/fmb.11.162
Alspaugh, J. A., Perfect, J. R., and Heitman, J. (1998). Signal transduction pathways
regulating differentiation and pathogenicity of Cryptococcus neoformans.
Fungal Genet. Biol. 25, 1–14. doi: 10.1006/fgbi.1998.1079
Bach, M. C., Tally, P. W., and Godofsky, E. W. (1997). Use of cerebrospinal
fluid shunts in patients having acquired immunodeficiency syndrome
with cryptococcal meningitis and uncontrollable intracranial hypertension.
Neurosurgery 41, 1280–1282. doi: 10.1097/00006123-199712000-00008
Banerjee, U., Gupta, K., and Venugopal, P. (1997). A case of prosthetic valve
endocarditis caused by Cryptococcus neoformans var. neoformans. J. Med. Vet.
Mycol. 35, 139–141. doi: 10.1080/02681219780001031
Bratton, E. W., El Husseini, N., Chastain, C. A., Lee, M. S., Poole, C.,
Stürmer, T., et al. (2012). Comparison and temporal trends of three groups with
cryptococcosis: HIV-infected, solid organ transplant, and HIV-negative/non-
transplant. PLoS ONE 8:e43582. doi: 10.1371/journal.pone.0043582
Braun, D. K., Janssen, D. A., Marcus, J. R., and Kauffman, C. A. (1994).
Cryptococcal infection of a prosthetic dialysis fistula. Am. J. Kidney Dis. 24,
864–867. doi: 10.1016/S0272-6386(12)80683-4
Brizendine, K. D., Baddley, J. W., and Pappas, P. G. (2011). Pulmonary
cryptococcosis. Semin. Respir. Crit. CareMed. 32, 727–734. doi: 10.1055/s-0031-
1295720
Brizendine, K. D., Baddley, J. W., and Pappas, P. G. (2013). Predictors
of mortality and differences in clinical features among patients with
Cryptococcosis according to immune status. PLoS ONE 8:e60431. doi:
10.1371/journal.pone.0060431
Casadevall, A., and Pirofski, L. (2001). Host-pathogen interactions: the attributes
of virulence. J. Infect. Dis. 184, 337–344. doi: 10.1086/322044
Chang, Y. C., and Kwon-Chung, K. J. (1994). Complementation of a capsule-
deficient mutation of Cryptococcus neoformans restores its virulence. Mol. Cell.
Biol. 14, 4912–4919. doi: 10.1128/MCB.14.7.4912
Frontiers in Microbiology | www.frontiersin.org 8 March 2016 | Volume 7 | Article 290
fmicb-07-00290 March 9, 2016 Time: 15:7 # 9
Benaducci et al. Cryptococcus sp. Biofilms in Galleria mellonella
Chang, Y. C., Penoyer, L. A., and Kwon-Chung, K. J. (1996). The second capsule
gene of Cryptococcus neoformans, CAP64, is essential for virulence. Infect.
Immun. 64, 1977–1983.
Cirasola, D., Sciota, R., Vizzini, L., Ricucci, V., Morace, G., and Borghi, E. (2013).
Experimental biofilm-related Candida infections. Future Microbiol. 8, 799–805.
doi: 10.2217/fmb.13.36
Corti, M., Priarone, M., Negroni, R., Gilardi, L., Castrelo, J., Arechayala, A. I., et al.
(2014). Ventriculoperitoneal shunts for treating increased intracranial pressure
in cryptococcal meningitis with or without ventriculomegaly. Rev. Soc. Bras.
Med. Trop. 47, 524–527. doi: 10.1590/0037-8682-0176-2013
Costerton, J. W., Lewandowski, Z., Caldwell, D. E., Korber, D. R., and Lappin-
Scott, H. M. (1995). Microbial biofilms. Annu. Rev. Microbiol. 49, 711–745. doi:
10.1146/annurev.mi.49.100195.003431
Cox, G. M., Harrison, T. S., McDade, H. C., Taborda, C. P., Heinrich, G.,
Casadevall, A., et al. (2000). Urease as a virulence factor in experimental
cryptococcosis. Infect. Immun. 68, 443–448. doi: 10.1128/IAI.68.2.443-448.2000
Cox, G. M., Harrison, T. S., McDade, H. C., Taborda, C. P., Heinrich, G.,
Casadevall, A., et al. (2003). Superoxide dismutase influences the virulence
of Cryptococcus neoformans by affecting growth within macrophages. Infect.
Immun. 71, 173–180. doi: 10.1128/IAI.71.1.173-180.2003
Del Poeta, M. (2004). Role of phagocytosis in the virulence of Cryptococcus
neoformans. Eukaryot. Cell 3, 1067–1075. doi: 10.1128/EC.3.5.1067-1075.2004
Desalermos, A., Fuchs, B. B., and Mylonakis, E. (2012). Selecting an invertebrate
model host for the study of fungal pathogenesis. PLoS Pathog. 8:e1002451. doi:
10.1371/journal.ppat.1002451
Desalermos, A., Tan, X., Rajamuthiah, R., Arvanitis, M., Wang, Y., Li, D., et al.
(2015). A multi-host approach for the systematic analysis of virulence factors in
Cryptococcus neoformans. J. Infect. Dis. 211, 298–305. doi: 10.1093/infdis/jiu441
Donlan, R. M., and Costerton, J. W. (2002). Biofilms: survival mechanisms of
clinically relevant microorganisms. Clin. Microbiol. Rev. 15, 167–193. doi:
10.1128/CMR.15.2.167-193.2002
Feder, V., Kmetzsch, L., Staats, C. C., Vidal-Figueiredo, N., Ligabue-Braun, R.,
Carlini, C. R., et al. (2015). Cryptococcus gattii urease as a virulence factor and
the relevance of enzymatic activity in cryptococcosis pathogenesis. FEBS J. 282,
1406–1418. doi: 10.1111/febs.13229
Firacative, C., Duan, S., and Meyer, W. (2014). Galleria mellonella model identifies
highly virulent strains among all major molecular types of Cryptococcus gattii.
PLoS ONE 9:e105076. doi: 10.1371/journal.pone.0105076
Fuchs, B. B., and Mylonakis, E. (2006). Using non-mammalian hosts to study
fungal virulence and host defense. Curr. Opin. Microbiol. 9, 346–351. doi:
10.1016/j.mib.2006.06.004
Fuchs, B. B. O., Brien, E., Khoury, J. B., and Mylonakis, E. (2010). Methods for
using Galleria mellonellaas a model host to study fungal pathogenesis. Virulence
1, 475–482. doi: 10.4161/viru.1.6.12985
García-Rivera, J., Chang, Y. C., Kwon-Chung, K. J., and Casadevall, A. (2004).
Cryptococcus neoformans CAP59 (or Cap59p) is involved in the extracellular
trafficking of capsular glucuronoxylomannan. Eukaryot. Cell 3, 385–392. doi:
10.1128/EC.3.2.385-392.2004
Grijpstra, J., Gerwig, G. J., Wösten, H., Kamerling, J. P., and de Cock, H. (2009).
Production of extracellular polysaccharides by CAP mutants of Cryptococcus
neoformans. Eukaryot. Cell 8, 1165–1173. doi: 10.1128/EC.00013-09
Hall-Stoodley, L., Costerton, J. W., and Stoodley, P. (2004). Bacterial biofilms: from
the natural environment to infectious diseases. Nat. Rev. Microbiol. 2, 95–108.
doi: 10.1038/nrmicro821
Hicks, J. K., and Heitman, J. (2007). Divergence of protein kinase A catalytic
subunits in Cryptococcus neoformans and Cryptococcus gattii illustrates
evolutionary reconfiguration of a signaling cascade. Eukaryot. Cell 6, 413–420.
doi: 10.1128/EC.00213-06
Kavanagh, K., and Reeves, E. P. (2004). Exploiting the potential of insects for
in vivo pathogenicity testing of microbial pathogens. FEMS Microbiol. Rev. 28,
101–112. doi: 10.1016/j.femsre.2003.09.002
Kraus, P. R., Fox, D. S., Cox, G. M., and Heitman, J. (2003). The Cryptococcus
neoformans MAP kinase Mpk1 regulates cell integrity in response to antifungal
drugs and loss of calcineurin function. Mol. Microbiol. 48, 1377–1387. doi:
10.1046/j.1365-2958.2003.03508.x
Kronstad, J. W., Attarian, R., Cadieux, B., Choi, J., D’Souza, C. A., Griffiths, E. J.,
et al. (2011). Expanding fungal pathogenesis: Cryptococcus breaks out of the
opportunistic box. Nat. Rev. Microbiol. 9, 193–203. doi: 10.1038/nrmicro2522
Kwon-Chung, K. J., Edman, J. C., and Wickes, B. L. (1992). Genetic association
of mating types and virulence in Cryptococcus neoformans. Infect. Immun. 60,
602–605.
Kwon-Chung, K. J., Polacheck, I., and Bennett, J. E. (1982). Improved diagnostic
medium for separation of Cryptococcus neoformans var. neoformans (serotypes
A and D) and Cryptococcus neoformans var. gattii(serotypes B and C). J. Clin.
Microbiol. 15, 535–537.
Livak, K. J., and Schmittgen, T. D. (2001). Analysis of relative gene expression data
using real-time quantitative PCR and the 2(-Delta DeltaC(T)) Method. Methods
25, 402–408. doi: 10.1006/meth.2001.1262
London, R., Orozco, B. S., and Mylonakis, E. (2006). The pursuit of cryptococcal
pathogenesis: heterologous hosts and the study of cryptococcal host-
pathogen interactions. FEMS Yeast Res. 6, 567–573. doi: 10.1111/j.1567-
1364.2006.00056.x
Martinez, L. R., Bryan, R. A., Apostolidis, C., Morgenstern, A., Casadevall, A.,
and Dadachova, E. (2006). Antibody-guided alpha radiation effectively
damages fungal biofilms. Antimicrob. Agents Chemother. 50, 2132–2136. doi:
10.1128/AAC.00120-06
Martinez, L. R., and Casadevall, A. (2005). Specific antibody can prevent fungal
biofilm formation and this effect correlates with protective efficacy. Infect.
Immun. 73, 6350–6362. doi: 10.1128/IAI.73.10.6350-6362.2005
Martinez, L. R., and Casadevall, A. (2006a). Cryptococcus neoformans cells in
biofilms are less susceptible than planktonic cells to antimicrobial molecules
produced by the innate immune system. Infect. Immun. 74, 6118–6123. doi:
10.1128/IAI.00995-06
Martinez, L. R., and Casadevall, A. (2006b). Susceptibility of Cryptococcus
neoformans biofilms to antifungal agents in vitro. Antimicrob. Agents
Chemother. 50, 1021–1033. doi: 10.1128/AAC.50.3.1021-1033.2006
Martinez, L. R., and Casadevall, A. (2015). Biofilm formation by Cryptococcus
neoformans. Microbiol. Spectr. 3, 1–11.
McClelland, E. E., Hobbs, L. M., Rivera, J., Casadevall, A., Potts, W. K., Smith,
J. M., et al. (2013). The role of host gender in the pathogenesis of Cryptococcus
neoformans infections. PLoS ONE 8:e63632. doi: 10.1371/journal.pone.0063632
Mendes-Giannini, M. J., Taylor, M. L., Bouchara, J. B., Burger, E., Calich, V. L.,
Escalante, E. D., et al. (2000). Pathogenesis II: fungal responses to host
responses: interaction of host cells with fungi. Med. Mycol. 38, 113–123. doi:
10.1080/mmy.38.1.113.123
Morrow, C. A., and Fraser, J. A. (2013). Is the nickel-dependent urease complex
of Cryptococcus the pathogen’s Achilles’ heel? MBio 4:e00408–e00413. doi:
10.1128/mBio.00408-13
Mylonakis, E., Ausubel, F. M., Perfect, J. R., Heitman, J., and Calderwood, S. B.
(2002). Killing of Caenorhabditis elegans by Cryptococcus neoformans as a
model of yeast pathogenesis. Proc. Natl. Acad. Sci. U.S.A. 99, 15675–15680. doi:
10.1073/pnas.232568599
Mylonakis, E., Moreno, R., El Khoury, J. B., Idnurm, A., Heitman, J., Calderwood,
S. B., et al. (2005). Galleria mellonella as a model system to study
Cryptococcus neoformans pathogenesis. Infect. Immun. 73, 3842–3850. doi:
10.1128/IAI.73.7.3842-3850.2005
Ngamskulrungroj, P., Himmelreich, U., Breger, J. A., Wilson, C.,
Chayakulkeeree, M., Krockenberger, M. B., et al. (2009). The trehalose synthesis
pathway is an integral part of the virulence composite for Cryptococcus gattii.
Infect. Immun. 77, 4584–4596. doi: 10.1128/IAI.00565-09
Perfect, J. R. (2005). Cryptococcus neoformans: a sugar-coated killer with
designer genes. FEMS Immunol. Med. Microbiol. 45, 395–404. doi:
10.1016/j.femsim.2005.06.005
Perfect, J. R. (2013). Fungal diagnosis: how do we do it and can we do better? Curr.
Med. Res. Opin. 29, 3–11. doi: 10.1185/03007995.2012.761134
Prates, R. A., Fuchs, B. B., Mizuno, K., Naqvi, Q., Kato, I. T., Ribeiro,
M. S., et al. (2013). Effect of virulence factors on the photodynamic
inactivation of Cryptococcus neoformans. PLoS ONE 8:e54387. doi:
10.1371/journal.pone.0054387
Pyrgos, V., Seitz, A. E., Steiner, C. A., Prevots, D. R., and Williamson, P. R. (2013).
Epidemiology of cryptococcal meningitis in the US: 1997-2009. PLoS ONE
8:e56269. doi: 10.1371/journal.pone.0056269
Qiu, Y., Davis, M. J., Dayrit, J. K., Hadd, Z., Meister, D. L., Osterholzer,
J. J., et al. (2012). Immune modulation mediated by cryptococcallaccase
promotes pulmonary growth and brain dissemination of virulent Cryptococcus
neoformans in mice. PLoS ONE 7:e47853. doi: 10.1371/journal.pone.0047853
Frontiers in Microbiology | www.frontiersin.org 9 March 2016 | Volume 7 | Article 290
fmicb-07-00290 March 9, 2016 Time: 15:7 # 10
Benaducci et al. Cryptococcus sp. Biofilms in Galleria mellonella
Rajasingham, R., and Boulware, D. R. (2015). HIV care: ART adherence support
and cryptococcal screening. Lancet 385, 2128–2129. doi: 10.1016/S0140-
6736(15)60455-X
Ramage, G., Rajendran, R., Sherry, L., and Williams, C. (2012). Fungal biofilm
resistance. Int. J. Microbiol. 2012, 528521. doi: 10.1155/2012/528521
Ramage, G., and Williams, C. (2013). The clinical importance of fungal biofilms.
Adv. Appl. Microbiol. 84, 27–83. doi: 10.1016/B978-0-12-407673-0.00002-3
Robertson, E. J., and Casadevall, A. (2009). Antibody-mediated immobilization
of Cryptococcus neoformans promotes biofilm formation. Appl. Environ.
Microbiol. 75, 2528–2533. doi: 10.1128/AEM.02846-08
Sardi, J. C., Pitangui, N. S., Rodríguez-Arellanes, G., Taylor, M. L., Fusco-Almeida,
A. M., and Mendes-Giannini, M. J. (2014). Highlights in pathogenic fungal
biofilms. Rev. Iberoam. Micol. 31, 22–29. doi: 10.1016/j.riam.2013.09.014
Sardi, J. C., Scorzoni, L., Bernardi, T., Fusco-Almeida, A. M., and Mendes-
Giannini, M. J. (2013). Candida species: current epidemiology, pathogenicity,
biofilm formation, natural antifungal products and new therapeutic options.
J. Med. Microbiol. 62, 10–24. doi: 10.1099/jmm.0.045054-0
Scorzoni, L., de Lucas, M. P., Mesa-Arango, A. C., Fusco-Almeida, A. M.,
Lozano, E., Cuenca-Estrella, M., et al. (2013). Antifungal efficacy
during Candida krusei infection in non-conventional models correlates
with the yeast in vitro susceptibility profile. PLoS ONE 8:e60047. doi:
10.1371/journal.pone.0060047
Smith, J. A., and Kauffman, C. A. (2012). Pulmonary fungal infections. Respirology
17, 913–926. doi: 10.1111/j.1440-1843.2012.02150.x
Sorrell, T. C. (2001). Cryptococcus neoformans variety gattii. Med. Mycol. 39,
155–168. doi: 10.1080/mmy.39.2.155.168
Stie, J., and Fox, D. (2012). Induction of brain microvascular endothelial cell
urokinase expression byCryptococcus neoformans facilitates blood-brain barrier
invasion. PLoS ONE 7:e49402. doi: 10.1371/journal.pone.0049402
Tortorano, A. M., Dho, G., Prigitano, A., Breda, G., Grancini, A., Emmi, V., et al.
(2012). ECMM-FIMUA Study Group. Invasive fungal infections in the intensive
care unit: a multicentre, prospective, observational study in Italy (2006-2008).
Mycoses 55, 73–79. doi: 10.1111/j.1439-0507.2011.02044.x
Trevijano-Contador, N., Herrero-Fernández, I., García-Barbazán, I., Scorzoni, L.,
Rueda, C., Rossi, S. A., et al. (2015). Cryptococcus neoformans induces
antimicrobial responses and behaves as a facultative intracellular pathogen
in the non mammalian model Galleria mellonella. Virulence 6, 66–74. doi:
10.4161/21505594.2014.986412
Uppuluri, P., and Lopez-Ribot, J. L. (2010). An easy and economical in vitro
method for the formation of Candida albicans biofilms under continuous
conditions of flow. Virulence 1, 483–487. doi: 10.4161/viru.1.6.13186
Walsh, T. J., Schlegel, R., Moody, M. M., Costerton, J. W., and Salcman, M.
(1986). Ventriculoatrial shunt infection due to Cryptococcus neoformans: an
ultrastructural and quantitative microbiological study. Neurosurgery 18, 373–
375. doi: 10.1097/00006123-198603000-00025
Wand, M. E., Bock, L. J., Turton, J. F., Nugent, P. G., and Sutton,
J. M. (2012). Acinetobacter baumannii virulence is enhanced in Galleria
mellonella following biofilm adaptation. J. Med. Microbiol. 61, 470–477. doi:
10.1099/jmm.0.037523-0
Williams, D. L., and Costerton, J. W. (2012). Using biofilms as initial inocula
in animal models of biofilm-related infections. J. Biomed. Mater. Res. B Appl.
Biomater. 100, 1163–1169. doi: 10.1002/jbm.b.31979
Williamson, P. R. (1994). Biochemical and molecular characterization of the
diphenol oxidase of Cryptococcus neoformans: identification as a laccase.
J. Bacteriol. 176, 656–664.
Wright, L. C., Payne, J., Santangelo, R. T., Simpanya, M. F., Chen, S. C., Widmer, F.,
et al. (2004). Cryptococcal phospholipases: a novel lysophospholipase
discovered in the pathogenic fungus Cryptococcus gattii. Biochem. J.
384, 377–384. doi: 10.1042/BJ20041079
Zaragoza, O., Rodrigues, M. L., de Jesus, M., Frases, S., Dadachova, E.,
and Casadevall, A. (2009). The capsule of the fungal pathogen
Cryptococcus neoformans. Adv. Appl. Microbiol. 6, 133–216. doi:
10.1016/S0065-2164(09)01204-0
Zhu, F., Ma, X. H., Qin, C., Tao, L., Liu, X., Shi, Z., et al. (2012).
Drug discovery prospect from untapped species: indications from approved
natural product drugs. PLoS ONE 7:e39782. doi: 10.1371/journal.pone.00
39782
Zhu, X., Gibbons, J., Garcia-Rivera, J., Casadevall, A., and Williamson, P. R. (2001).
Laccase of Cryptococcus neoformans is a cell wall-associated virulence factor.
Infect. Immun. 69, 5589–5596. doi: 10.1128/IAI.69.9.5589-5596.2001
Conflict of Interest Statement: The authors declare that the research was
conducted in the absence of any commercial or financial relationships that could
be construed as a potential conflict of interest.
Copyright © 2016 Benaducci, Sardi, Lourencetti, Scorzoni, Gullo, Rossi, Derissi, de
Azevedo Prata, Fusco-Almeida and Mendes-Giannini. This is an open-access article
distributed under the terms of the Creative Commons Attribution License (CC BY).
The use, distribution or reproduction in other forums is permitted, provided the
original author(s) or licensor are credited and that the original publication in this
journal is cited, in accordance with accepted academic practice. No use, distribution
or reproduction is permitted which does not comply with these terms.
Frontiers in Microbiology | www.frontiersin.org 10 March 2016 | Volume 7 | Article 290
